These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 6158092)
21. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040 [TBL] [Abstract][Full Text] [Related]
22. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves. De Ley G; De Moor A Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389 [TBL] [Abstract][Full Text] [Related]
23. CSF-changes of HVA and 5-HIAA during intermittent and continuous Parkinson therapy with particular regard to prodipin application. Oppel F; Schulze G Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):76-80. PubMed ID: 347467 [TBL] [Abstract][Full Text] [Related]
24. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data]. Carrieri P; Mandarini A; Campanella G Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845 [No Abstract] [Full Text] [Related]
25. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients. Kirstein L; Bowers MB; Heninger G Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133 [TBL] [Abstract][Full Text] [Related]
27. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients. Jori A; Dolfini E; Casati C; Argenta G Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms. Banki CM; Molnar G; Vojnik M J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645 [TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid levels of cyclic nucleotides and monoaminergic metabolites in subarachnoid haemorrhage: preliminary report. Gerosa MA; Olivi A; Longatti PL; Teolato A; Carteri A Neurochirurgia (Stuttg); 1981 Mar; 24(2):64-6. PubMed ID: 6163998 [TBL] [Abstract][Full Text] [Related]
30. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320 [TBL] [Abstract][Full Text] [Related]
31. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid. Gateless D; Stanley M; Träskman-Bendz L; Gilroy J Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808 [No Abstract] [Full Text] [Related]
32. [Cerebrospinal fluid levels of HVA and 5-HIAA in epileptic patients: effect of total sleep deprivation]. Livrea P; Di Reda L; Papagno G Acta Neurol (Napoli); 1976; 31(5):632-6. PubMed ID: 827926 [No Abstract] [Full Text] [Related]
33. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus. Inagawa T; Ishikawa S; Uozumi T J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788 [TBL] [Abstract][Full Text] [Related]
34. Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices. Agren H; Terenius L J Affect Disord; 1985 Jul; 9(1):25-34. PubMed ID: 2410472 [TBL] [Abstract][Full Text] [Related]
35. 5-Hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid below partial and complete spinal subarachnoid block. Massarotti M; Roccella P; Toffano G Eur Neurol; 1978; 17(3):174-80. PubMed ID: 658062 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables. Banki CM; Vojnik M; Molnar G J Affect Disord; 1981 Jun; 3(2):81-9. PubMed ID: 6166644 [TBL] [Abstract][Full Text] [Related]
37. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate]. Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166 [No Abstract] [Full Text] [Related]
38. Stability of monoamine metabolites in human cerebrospinal fluid. Langlais PJ; Bird ED; McEntee WJ Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677 [TBL] [Abstract][Full Text] [Related]
39. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects. Nordin C; Siwers B; Bertilsson L Acta Psychiatr Scand; 1981 Jul; 64(1):25-33. PubMed ID: 6172006 [TBL] [Abstract][Full Text] [Related]
40. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]